SCHEMBL8998873

SCHEMBL8998873

Cc1ccc(C(=O)c2ccccc2C(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.51
LMNA P02545 4/20 0.50
ALDH1A1 P00352 4/20 0.50
GAA P10253 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPT P10636 2/20 0.49
ALOX12 P18054 1/20 0.49
CNR2 P34972 2/20 0.48
KCNK3 O14649 1/20 0.47
KCNK9 Q9NPC2 1/20 0.47
SRD5A2 P31213 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
RORC P51449 1/20 0.44
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31369140 0.85 GAA (0.56) AKR1C3SMN1; SMN2LMNAALDH1A1GAA
SCHEMBL3717986 0.85 GAA (0.56) AKR1C3SMN1; SMN2LMNAALDH1A1GAA
SCHEMBL7483674 0.84 LIG1 (0.59) SMN1; SMN2LMNAGAAMAPTCNR2
SCHEMBL11756092 0.82 SMN1; SMN2 (0.48) SMN1; SMN2LMNAGAAMAPTCNR2
SCHEMBL7479627 0.82 KMT2A (0.60) SMN1; SMN2LMNAALDH1A1MAPTCES2
SCHEMBL11189754 0.81 AKR1C3 (0.84) AKR1C3SMN1; SMN2LMNAALDH1A1TDP1
SCHEMBL746794 0.81 LMNA (0.64) SMN1; SMN2LMNAGAACNR2KCNK3
SCHEMBL2319290 0.80 LMNA (0.47) SMN1; SMN2LMNAALDH1A1GAACNR2
SCHEMBL28770832 0.80 AKR1C3 (0.56) AKR1C3SMN1; SMN2LMNAALDH1A1GAA
SCHEMBL8550050 0.79 TDP1 (0.46) AKR1C3LMNAALDH1A1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5554624-A CONGESTIVE HEART FAILURE; HYPOTENSIVE AGENTS J. URIACH & CIA. (ES) 1996-09-10 US disclosed
EP-0669333-A1 New imidazopyridine derivatives as angiotensin II antagonists J. URIACH & CIA. S.A. (ES) 1995-08-30 EP disclosed